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Introduction
Bone undergoes remodeling throughout life. Remodeling begins with bone
resorption by osteoclasts and is followed by bone formation by osteoblasts. Resorption is
said to be coupled to formation. Extracellular calcium, which inhibits osteoclastic
activity while stimulating chemotaxis and mitogenesis of osteoblasts, may serve as a key
coupling agem between bone formation and resorption, by inhibiting (Godwin, et al.,
1996). Osteoporosis results from an imbalance in the functions of forming and resorbing
cells.
When a force is applied to a tooth during orthodontic treatmem, a pressure is
generated along one side and a tension is generated along the other side ofthe root of the
tooth (Storey, 1973). The bone lining the pressure side ofthe root undergoes resorption,
allowing for movemem ofthe root in that direction, and the tension side ofthe root
undergoes bone formation. Therefore, resorption-formation allows for root movemem
through bone without a net loss or gain oftotal bone. Studies have shown that
prostaglandins may play an important role in tooth movement (Yamasaki, et al., 1996).
In this study, we examined the effects of extracellular calcium on expression of
cyclooxygenase-2 (COX-2), a limiting enzyme in the production ofprostaglandins (PGs)
from membrane lipids (Herscbmaan, 1994). Prostaglandins are important in regulating
bone remover and have been shown to enhance tooth movemem (Yamasaki, et al., 1996).
Specifically, we examined the induction of COX-2 mRNA in osteoblastic cells by
extracellular calcium and determined if the induction is transcriptionally mediated.
Background
Regulation of cell function by calcium
Calcium, a divalent cation, plays very important roles in intracellular and
extracellular functions. Intracellular calcium regulates a variety of cell functions,
including processes as diverse as muscle contraction, hormonal secretion, glycogen
metabolism, and cell division (Seibel, et al., 1995). Calcium binding to intracellular
proteins, such as calmodulin, enzymes or other cellular effector systems are activated and
cell functions are accomplished.
Intracellular calcium
The intracellular free calcium concentration is about 100-200 nM, whereas the
concentration within intracellular organelles is 1-20 tM. Extracellular calcium
concentration is about 1.2 mM and is under rigid comrol. As stated, there exists a 5,000
to 10,000 fold concentration gradient and a transmembrane electrical gradiem that favors
movement of calcium into the negatively charged cell. Mechanisms exist that maintain
this concentration gradient.
Cells remain inactive at low Ca+ concemrations (10-100 nM range) (Berridge, et
al, 1996). When higher concentrations of calcium are reached (500-1000 nM range),
cells are activated to perform their particular functions. These changes in Ca2+
concentration are detected by sensors such as calmodulin and troponin C, which
transduce the information imo specific cellular responses. Ca2+ can be derived from the
extracellular environment, through channels in the plasma membrane, or it can be
released from imernal stores, such as the endoplasmic reticulum or sarcoplasmic
reticulum in muscle. These are known as the calcium-ON mechanisms, whereby Ca2+
enters the cytoplasm. Conversely, calcium-OFF mechanisms exist to remove Ca2+ from
the cytoplasm, by pumping it either out ofthe cell or back into the internal stores
(Berridge, et al., 1996).
Various channels are present in the plasma membrane that mediate the influx of
external Ca+ (Berridge, et al., 1996). Voltage-operated channels are found in excitable
cells (nerve, muscle, and certain endocrine cells) and open when membrane
depolarization occurs to allow extracellular Ca2+ to enter the cell. These channels can be
regulated both by receptor-mediated and intracellular messenger (ex. cyclic AMP)
systems. Receptor-operated channels are activated by binding of extracellular agonists,
which are usually neurotransmitters (ex. glutamate and ATP). Calcium-release activated
Ca2+ channels (CRAC’s) are located in the plasma membrane and inhibit Ca2+ entry into
the cell when the ER is fully loaded. Conversely, when the ER stores are dwindling,
calcium influx factor diffuses to the membrane and opens the CRAC’s to allow Ca2+
entry.
Intracellular calcium channels responsible for releasing Ca2+ from the intracellular
stores are inositol 1,4,5-triphosphate receptors (InsP3Rs) and ryanodine receptors (RyRs)
(BelTidge, et al., 1996). InsP3 diffuses imo the cytoplasm, binds to its receptor and
releases stored Ca2+. The most important diffusible messenger for activating InsP3R and
RyR is Ca2+ itself. The process of Ca2+ induced Ca2+ release is of fundamemal
importance in regulating the way in which cells mobilize Ca2+ from their internal stores.
Calcium OFF mechanisms fimction to return Ca2+ either to internal stores or back
to the external medium (Berridge, et al., 1996). The Na+/Ca2+ exchanger is found in the
plasma membrane and utilizes the energy stored in the electrochemical Na+ gradient to
extrude Ca2+ from the cell. Plasma membrane Ca2+ ATPases utilize the energy ofATP to
transport Caz+ against the enormous electrochemical gradiem that exists across the
plasma membrane. The sarco/endoplasmic reticulum Ca2+ ATPase pumps are found on
the membranes of intracellular stores and they sequester Ca2+ found in the cytoplasm.
Ca+ binding proteins contribute to Ca2+ mediated signaling, either by buffeting
free Ca2+ ions or by acting as sensors that mediate the messenger role ofCa+ (Berridge,
et al., 1996). Proteins capable ofbuffeting Ca2+ are found in both the cytoplasm and
within the ER/SR. Examples ofbuffeting proteins include parvalbumin, calretinin and
calbindin.
Extracellular calcium and regulation of bone rnover
Elevation of extracellular calcium has been shown to inhibit osteoclastic bone
resorption and stimulate proliferation and chemotaxis of osteoblasts as well as monocytes
(Godwin, et al., 1997; Sugimoto, 1993). Therefore, calcium released by bone resorption
may have an important role in the coupling ofbone resorption and bone formation.
Although both osteoclasts and osteoblasts have calcium-sensing mechanisms, it is still
controversial whether these cells express the same extracellular Ca+ receptor (CAR) as
that identified in parathyroid and kidney cells.
Calcium receptors in parathyroid cells
Extracellular Ca2+ acts on parathyroid cells to regulate PTH secretion. The
calcium receptor was first cloned from parathyroid cells where it ftnctions as the
principal regulator ofPTH secretion (Brown, et al., 1993). This receptor is a G protein-
coupled receptor whose primary physiological ligand is extracellular Ca2+ (Nemeth,
1996). This cell surface Ca2+ receptor (CAR) enables parathyroid cells to detect and
respond to small changes in the concentration of extracellular Ca2+. Extracellular
calcium acting on the CaR increases the activity ofphospholipase C, thereby producing
inositol 1,4,5-triphosphate and mobilizing intracellular Ca2+ The CaR is found in high
concentrations on the surface ofparathyroid cells, on calcitonin-secreting C-cells of the
thyroid, at various sites along the nephron, and in certain areas ofthe brain (Cobum et al.,
1999).
In differem tissues ofthe same species, the Ca2+ receptor has been shown to be
identical to that expressed in parathyroid cells (Nemeth, 1996). The human parathyroid
CaR possesses an unusually large NH2-terminal extracellular domain with 11 potential
glycosylation sites, a membrane spanning domain comaining seven membrane-spanning
regions, and a relatively large COOH-terminal cytoplasmic domain. The CaR shares
limited homology only with metabotropic glutamate receptors (mGluRs) (Nemeth, 1996).
Analysis ofthe sequence ofthe CaR suggests a likely role ofthe extracellular domain in
binding extracellular Ca2+ and activating the receptor. Similarly, mGluRs have the
extracellular binding domain for glutamate. Since the CaR is designed to sense plasma
levels of 2+Ca its affinity for extracellular Ca2+ is presumably in the millimolar range.
There are regions ofthe receptor that are enriched with acidic amino acids. Since these
regions are enriched in negative charges, this could play a role in binding extracellular
Ca2+.
The CaR is relatively indiscriminate with respect to ions or compounds
possessing net positive charges, such as: La3+> Gd3+ > Be2+ > Ca+= Ba+ > Sr+ > Mg2+
(Nemeth, 1996). Likewise, many organic polycations activate the CaR, including simple
polyamines (spermine), aminoglycoside antibiotics (neomycin), and polyamino acids
(polylysine) or proteins (protamine). All these organic and inorganic polycations
mobilize intracellular Ca2+ and inhibit hormone secretion in parathyroid cells in vitro.
They do so, moreover, in the absence of extracellular Ca2+. Various clinical disorders
may arise when there is a mutation affecting the CaR, in which the CaR becomes either
more or less sensitive to calcium (Cobum, et al., 1999). Mutations in the CaR causing it
to be less sensitive to extracellular calcium can lead to familial hypocalciuric
hypercalcemia in heterozygotes or to severe infantile hyperparathyroidism in
homozygotes. Mutations in the CaR causing it to be more sensitive to extracellular
calcium can lead to hereditary forms ofhypopamthyroidism.
Calcimimetic drugs, which amplify the sensitivity ofthe CaR to calcium, can
suppress PTH levels, leading to a fall in blood calcium and may be useful therapeutic
agents for some diseases of calcium metabolism such as hyperparathyroidism. The first
class ofcompounds that can be considered selective pharmacological probes of the Caz+
receptor are phenylalkylamines typified by NPS R-568 (Nemeth, 1996). A study was
done in rats with experimental uremia, to demonstrate the effects ofNPS R-568 on a
model of secondary hyperparathyroidism, in which there is a proliferation of parathyroid
cells. It was found that after 4 days oftreatmem, the degree ofproliferation ofthe
parathyroid cells-was reduced by 50% by high doses ofNPS R-568. In another study of
uremic rats with osteitis fibrosa, two different doses ofNPS R-568 were given daily for
30 days (Coburn, et al., 1999). A dose-related reduction ofPTH levels and marked
improvement in the degree of osteitis fibrosa were seen.
CaR in other tissues
Transcripts of the CaR have been found within the kidney in the following sites"
the jtLxtaglomemlar apparatus, along the luminal proximal convoluted tubule, the
basolateral surface ofthe cortical thick ascending limb, and the apical and luminal
membrane ofthe inner medullary collecting duct (Coburn, et al., 1999). The effect of
hypercalcemia to lower GFR, to cause increased urinary excretion of Ca+, and to lead to
increased volumes of dilute urine may arise through activation ofthe CaR within various
parts ofthe nephron. Varying levels of CaR expression have also been demonstrated in
diverse regions ofthe brain using immunohistochemistry and in situ hybridization with
CaR specific antisera and probes (Yamaguchi, et al., 2000).
2+Extracellular Ca -sensing mechanisms on bone cells
There are grounds to believe that both osteoblasts and osteoclasts possess some
mechanism capable of sensing extracellular Ca2+ (Nemeth, 1996). During bone
remodeling, osteoclasts and osteoblasts function in local environments characterized by
dramatic fluctuations in extracellular Ca+ concentrations (Silver et al., 1988). Increased
concentrations of extracellular Ca2+ elicit increases in intracellular Ca2+ in osteoclasts and
alter their morphology, and these effects are associated with an inhibition ofbone
resorption in vivo (Coburn, et al., 1988). High concentrations of extracellular Ca2+ (3
10 mM) are required to affect the behavior of osteoclasts. Calcimimetic compounds are
generally ineffective in altering intracellular Ca+ in osteoclasts, suggesting that the
putative receptor on the osteoclast is structurally distinct from that on parathyroid cells
(Cobum, et al., 1999). Fukmnoto (1998), showed through functional and histological
studies that the calcium-sensing mechanism in osteoclasts is a ryanodine receptor-like
molecule in the plasma membrane, while the calcium sensing mechanism in osteoblasts
may be similar to the calcium receptor identified in the parathyroid gland.
The nature ofthe receptor mediating the effects of Ca2+ on osteoblasts is also
debated. Increasing the concentration of extracellular Caz+ above 3mM stimulates DNA
synthesis in osteoblast-like MC3T3-E1 cells (Sugimoto, et al., 1993). The proliferative
effect of extracellular Ca2+ may be mediated by increased production of insulin-like
growth factors (Sugimoto, et al., 1994). The receptor mediating this effect on
proliferation appears to be structurally differem from the CaR present on parathyroid
cells because a variety of osteoblast-cell lines, including MC3T3-E1 cells, do not express
mRNA for the CaR and because increased concentrations of extracellular Ca+ do not
evoke corresponding increases in intracellular Ca2+ in osteoblast-like cells (Nemeth,
1996).
On the other hand, some studies suggest that the receptor for Ca2+ on osteoblasts
is similar to the CaR. Recently, in the mouse osteoblastic cell line MC3T3-E1, it was
shown through both immunocytochemistry and Western blot analysis, using an antiserum
specific for the CaR, that CaR protein was detected in these cells (Yamaguchi et al.,
2000). Northern analysis also confirmed the presence ofCaR transcripts. Exposure of
MC3T3-E1 cells to high Ca+ (up to 4.8 mM) or the polycationic CaR agonists, neomycin
and gadolinium, stimulated both chemotaxis and DNA synthesis in MC3T3-E1 cells
(Yamaguchi et al., 2000).
Yamaguchi et al. (2000) have recemly demonstrated the expression of CaR
transcripts and protein in several osteoblastic cell lines, including murine MC3T3-E1
cells, using multiple detection methods. To date however, there has been no rigorous
documentation ofthe CaR’s involvemem in the regulation of osteoblast function. Several
studies have reported that Caa+-activated K+ channels similar to those presem in and
activated by the CaR in neurons and lens epithelial cells are also expressed in primary
cultures of chick osteoblasts as well as in the human clonal osteoblastic cell lines G292,
MG-63, mad SaOS-2 (Yamaguchi, et al., 2000). If CaZ+-activated K+ channels in
osteoblastic cells are regulated by the CaR in a manner similar to those in neurons and
lens epithelial cells, such channels could provide a useful parameter for showing that the
CaR is not only expressed in osteoblastic cells but is also functionally active. It was
found that the Ca+ receptor expressed by MC3T3-E1 cells is functionally coupled to a
2+Ca -activated K+ channel, as revealed by its activation on raising the level of
extracellular calcium or addition ofthe selective CaR activator, NPS R-467, but not by
the less active stereoisomer, NPS S-467 (Yamaguchi, et al., 2000).
In MC3T3-E1 cells, a concentration-dependent increase in chemotaxis was
demonstrated between 1.8 and 5 mM ofCa2+ (Godwin, et al., 1996). Evidence for
receptor-mediated signaling by extracellular calcium was indicated by results obtained
using two inhibitors, pertussis toxin and U-73122. Pertussis toxin, an inhibitor of G-
protein activation, blocked almost all ofthe extracellular CaZ+-stimulated chemotaxis.
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This result suggests that a G-protein linked receptor must be involved in extracellular
Ca2+-mediated chemotaxis. Signaling events downstream of G-protein linked receptors
include the stimulation ofphospholipase C (PLC) activity. In the presence ofU-73122,
which blocks the activation ofPI-PLC, extracellular Ca2+-directed chemotaxis was
almost completely inhibited. This result indicates that extracellular Ca2+ -mediated
chemotaxis ofMC3T3-E1 cells requires PLC (Godwin et al., 1996).
Prostaglandins and tooth movement
The precursor for prostaglandins (PGs) and leukotrienes is arachidonic acid,
which is released from the phospholipids ofthe cell membrane by the action of
phospholipase enzymes. Arachidonic acid is metabolized by two main enzyme
pathways: cyclooxygenase and lipoxygenase. Cyclooxygenase activity results in the
formation ofPGs and thromboxanes. Lipoxygenase activity results in the formation of
leukotrienes and HETE’s (Herschman, 1994).
PGs may play an important role in tooth movemem. Tooth movemem requires
both bone resorption and new bone formation, and PGs can stimulate both processes
(Pilbeam et al., 2002). PGs produced by osteoblasts are potent stimulators of bone
resorption. Many studies indicate that PGs promote the differemiation of osteoclasts
from hematopoietic precursors and enhance the effects of other resorption agonists
(Okada et al., 2000; Pilbeam et al., 2002). Yamasaki et al. (1980), demonstrated on a rat
model that injection ofPGs increased osteoclast numbers. Clinical use ofPGE has been
shown to increase the efficiency of orthodomic tooth movement (Sandy, et al., 1993).
Indomethacin, a cyclooxygenase inhibitor, which inhibits PG synthesis, blocked the
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appearance of osteoclasts (Yamasaki, et al., 1980). Chumbley et al. (1986), showed that
with indomethacin administration, the rate oftooth movement in the experimental group
was approximately one half ofthe controls in mongrel cats. This reflects the importance
ofprostaglandins’ role in bone resorption during orthodontic tooth movement.
It has been shown that prostaglandins ofthe E series are the prostaglandins with
greatest activity in bone (Norrdin, et al., 1990). They are found in areas ofbone
resorption, inflammation, and sites oftooth movement. With pharmacological
administration ofprostaglandins, bone formation is also seen. In this way, prostaglandins
are involved in both bone resorption and bone formation (Norrdin, et al., 1990).
Cyclooxygenase-2
Cyclooxygenase (COX) is the major rate-limiting enzyme that converts
arachidonic acid released from membranes imo prostanoids (Pilbeam et al., 2002).
There are two isoemzymes encoded by separate genes for COX, COX-1 and COX-2.
COX-1 is constitutively expressed in bone and COX-2 is inducible. Many factors that
regulate bone metabolism also regulate the expression ofCOX-2 in osteoblasts. Acute
PG responses in bone to cytokines, growth factors and hormones are dependent on the
expression of COX-2.
Hypothesis
We hypothesize that extracellular calcium can induce COX-2 expression and PG
production in osteoblasts and that this induction is transcriptionally mediated.
Specific Objectives
Aim 1. To examine the effects of increasing extracellular Ca2+ concentration on steady
state levels ofCOX-2 mRNA levels in cultured primary calvarial osteoblasts.
Aim 2. To demonstrate that the Ca2+ -induced changes in COX-2 mRNA expression are
translated into COX-2 protein expression and PG production
Aim 3. To correlate the changes in COX-2 mRNA expression with luciferase activity
using primary osteoblasts from calvariae ofmice transgenic for COX-2 promoter--
luciferase reporter DNA (Pluc mice).
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Materials and Methods
Materials
Mudne COX-2 complementary DNA (cDNA) and DNA constructs consisting of-371 to
+70 base pairs ofthe COX-2 promoter fused to a luciferase reporter gene in pXp-2 vector
(Pluc) were donated by Harvey Herschman (UCLA, Los Angeles, CA). Transgenic mice
carrying Pluc were developed in a CD-1 background at the University of Connecticut
Transgenic Animal Facility. Polymerase chain reaction (PCR) was used to amplify
cDNA for glyceraldehydes-3-phosphate dehydrogenase (GAPDH) with a control
amplifier purchased from Clomech (Palo Alto, CA). Puromycin was purchased from
Biomol (Plymouth Meeting, PA). COX-2 antibodies were purchased from Caymen
Chemicals (Ann Arbor, MI). All other chemicals were purchased from Sigma (St. Louis,
MO).
Primary osteoblastic cells
Primary osteoblastic cells were obtained by sequemial digestion ofneonatal Pluc mice
calvaria. Calvariae were excised, stripped ofconnective tissue, and washed with
phosphate-buffered saline (PBS). Sequential digestions with collagenase P and trypsin
were performed to yield 5 populations of cells and populations 2-5 were pooled in 10%
FCS-DMEM media and grown to confluence before replating for the experiments. Cells
for experiments were plated at 5,000 cells/cm2 in 6-well culture dishes in a phenol red-
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free DMEM with 10% hem-inactivated FCS, penicillin (100 U/ml), and streptomycin (50
microgram/ml) and grown to confluence over 6 days. All cells were cultured at 37
degrees C in a humidified atmosphere of5% CO2 in air. On the 7th day, cells were
treated with added calcium in the form ofCaC12 in sermn-free DMEM containing 1
mg/ml BSA. CaCI was added in the amount necessary to bring the basal calcium
concentration of 1.8 mM in the DMEM up to the required concentration.
Northern blot analysis
Total RNA was extracted using Tri-Reagent (MRC, Cincinnati, OH). The
manufacturer’s instructions were followed. 10-20 micrograms oftotal RNA were run on
a 1% agarose-2.2 M offormaldehyde gel, transferred to a nylon membrane by capillary
pressure and fixed to the membrane by UV radiation. After 3 hours ofprehybridization
in a 50% formamide solution at 42 degrees C, filters were hybridized overnight in a
similar solution in rotating cylinders at the same temperature with a random (32p)
deoxycytosine triphosphate (dCTP)-labeled cDNA probe for COX-2 and later for
GAPDH. Filters were washed in a lx SSC, 1% sodium dodecyl sulfate (SDS) solution at
65 degrees C, and three more times in the latter solution at room temperature. After
washing, the filters were exposed to Kodak XAR-5 film (Eastman Kodak Co., Rochester,
NY) at-70 degrees C. Signals were normalized to GADPH. Bands were scanned into
the computer and the band density was quantified by the National Institute ofHealth
(NIH) Image 1.61 software.
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Western blot analysis
Cells were washed with PBS two times, lysed with SDS buffer (62.5 mM ofTris-HC1,
pH 6.8, 2% wt/vol SDS, 10% glycerol, 50 mM of dithiothreitol (DTT), and 0.1% wt/vol
bromphenol blue), and scraped into a microcentrifuge tube. The extraction mixture was
centrifuged at 14,000 g for 30 minutes. The supematants were sonicated 10-15 s, heated
to 95 degrees C for 5 minutes, cooled on ice, and centrifuged for 5 minutes. Equal
amounts ofprotein (25 microgram), determined by BCA assay, were run on a 10% SDS-
polyacrylamide gel and electrotransferred to a nitrocellulose membrane. Membranes
were washed with Tris-buffered saline (TBS; pH 7.6), blocked with blocking buffer (Ix
TBS, 0.1% Tween-20 with 5% wt/vol dry skim milk), and incubated with primary
antibody in blocking buffer. After washing with TBS with 0.1% Tween-20 (TBST), the
membrane was incubated with horseradish peroxidase (HRP)-conjugated secondary
antibody and HRP-conjugated antibiotin antibody. After washing with TBST, the signal
was detected with LumiGLO chemiluminescem reagent (New England Biolabs).
Medium PGE2 analysis
PGE2 levels in the culture medium were measured by radioimmunoassay using antibody
purchased from Dr. Lawrence Levine (Brandeis University, Waltham, MA) as previously
described (Raisz, 2001). The lower detection limit ofthe assay for PGE2 was 50 pg/ml or
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0.14 nM. The means and standard error ofthe mean (SEM) were calculated for n=3
wells in each group.
Luciferase Assay
Cells were lysed using a commercially available kit (Promega, WI), and the supematant
assayed for luciferase activity with a Berthold LB 9501/16 luminator (Wallac,
Gaithersburg, MD). Luciferase activity, in counts per second, was normalized to total
protein in sample by bichoninic acid assay. The mean + SEM was calculated for n=3
wells for each group, and each experiment was repeated three times.
Statistical Analysis
The statistical significance ofthe differences among the means was determined by
analysis ofvariance (ANOVA), with post-hoc comparison ofmore than two means by
Bonferroni method. The computer program Sigma Stat (Jandel Scientific, San Rafael,
CA) was used to run the statistics.
Results
Time coursefor the induction ofCOX-2 mRNA by Ca:+
Calvafial osteoblastic cultures were treated with 5 mM Ca2+, and the expression of
COX-2 mRNA determined by Northem blot analysis over a period of24 h. COX-2
mRNA was not detectable in vehicle-treated cultures (Figure 1). Induction ofCOX-2
mRNA was seen as early as 30 minutes. COX-2 mRNA (normalized to GAPDH mRNA)
peaked at 6-9 h. The COX-2 mRNA level remained elevated at 24 h.
Dose response _for the induction o_fCOX-2 mRNA andprotein expression by, Ca:+
Cultures ofprimary calvafial cells were treated for 6 h with Ca2+ at increasing
doses and Northern blot analysis was performed (Figure 2). Ca2+ levels were raised
through addition of CaC12 as described in Methods and Materials. The basal Ca2+
concentration in the culture medium was 1.8 mM. There was a dose-dependent increase
in COX-2 mRNA (normalized to GAPDH). COX-2 mRNA expression was induced at 3
mM ofCa2+ and peaked at 7.5 mM calcium.
The induction ofCOX-2 protein was examined by Western blot (Figure 2). The
induction ofCOX-2 protein by increasing Ca2+ was studied after 6 h oftreatment. There
was a dose dependent rise in COX-2 protein levels with administration ofCa2+.
Induction ofCOX-2 protein was seen at 3 mM Ca2+ and induction peaked at 20 mM Ca2+.
17
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Cae+ induction ofPGE_production
Cumulative medium PGE2 production was assayed in cultures of calvarial osteoblasts
treated with 5 mM Ca2+ for up to 24 h. (Figure 3). In vehicle-treated cultures, levels of
PGE2 were at the lower detection limits ofthe assay (50 pg/ml) and did not change over
the 24 h period. In cultures treated with 5 mM ofCa2+, cumulative PGE2 levels were
increased at 3 h and continued to rise over the 24 h period. The steepest rise in
cumulative PGE2 levels was between 3 and 9 h. At 24 h, cells treated with Ca2+ had
accumulated 9000 pg/ml ofPGE2, approximately 200 times the accumulation in vehicle-
treated cells.
Cae+ induction o_fCOX-2promoter activi_ inprima_ osteoblasts
The cells used in the above experiments were derived from mice transgenic for
371/+70 bp ofthe murine COX-2 promoter fused to a luciferase reporter gene. To
determine if the induction ofCOX-2 gene expression was transcriptionally mediated,
similar experiments were performed as above and luciferase activity was measured.
Luciferase activity was normalized to total protein in the sample to account for changes
in cell number.
The time course for stimulation of luciferase activity in calvarial osteoblasts is
shown in Figure 4. Cells were treated with 5 mM Ca2+. Ca2+ stimulated an 8-fold
increase in luciferase activity, with the peak effect occurring at 6 h. The dose response
for the Ca2/ induction ofCOX-2 promoter activity in primary osteoblasts is shown in
Figure 5. Cells were treated for 6 h. Luciferase activity rose with increasing Ca2/ doses
of 1.8, 3, 5, and 7.5 mM, peaking at 10 mM calcium.
Discussion
We examined the regulation ofCOX-2 and PGE2 production by extracellular Ca2+
in primary calvarial osteoblasts. COX-2 mRNA was not detectable in vehicle-treated
cultures (1.8 mM Ca2+ ) but was rapidly induced by addition ofCa+ to the medium. The
induction ofCOX-2 mRNA was seen as early as 30 min, peaked at 6-9 h, and mRNA
levels continued to be elevated at 24 h. Induction was dose-dependent, beginning at 3
mM and peaking at 10 mM. Ca+ also induced COX-2 protein expression dose-
dependently, but the peak effect occurred at 20-40 mM. The difference in peak effects of
Ca2+ on COX-2 mRNA and protein suggest that the higher concentrations ofCa2+ may
have effects on COX-2 protein expression. It is possible that high levels ofCa2+ could
increase translation ofCOX-2 mRNA into protein or increase the half-life ofCOX-2
protein by inhibiting enzymes responsible for the degradation ofCOX-2 protein.
Measuremem of cumulative medium PGE2 in calvarial osteoblasts treated with
Ca2+ (5 mM) showed that Ca2+ markedly induced PGE2 production. Despite the
constitutive expression ofCOX-1 in these cells, little PGE2 was produced in vehicle-
2+treated cultures. The rise in PGE2 in Ca -treated cells correlated with the time course for
the 2+Ca -nduction ofCOX-2 mRNA. Because Ca2+ induced COX-2 mRNA and protein
expression from undetectable levels, it is not possible to correlate the amplitude of
mRNA or protein induction with the amplitude ofPGE2 induction. Moreover, since the
levels ofPGE in control cultures were at the lower limit of detection in the assay, the
calculation ofthe Ca2+ induced PGE2 increase (about 200-fold) may be an
underestimate. Ca2+ is the most potem inducer ofPGE2 production in these cells by any
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agent examined to date (Pilbeam, unpublished observations). It is possible that Ca+ may
also be regulating the activity ofphospholipases that release the substrate for COX-2,
arachidonic acid, in these cells.
Ca2+ also induced luciferase activity in these primary calvarial cells which carried
a transgene consisting of 371 bp ofthe COX-2 promoter fused to a luciferase reporter.
The induction ofCOX-2 promoter activity paralleled the induction of COX-2 mRNA in
both time course and dose response. Hence, the Ca2+-induction ofCOX-2 expression
appears to be largely transcriptionally mediated. The goal now will be to identify the
sites in the COX-2 promoter (and the transacting factors binding to them) which are
involved in the transcriptional induction.
Another future goal will be to determine the signaling pathways involved in the
Ca+ induction ofCOX-2 expression in osteoblasts. Fluid shear stress can also induce
COX-2 expression in osteoblasts (Wadhwa et al., 2002). Inhibition ofthe mitogen
activiated protein kinase pathway (ERK) could largely prevent this induction. The ERK
pathway has previously been shown to be involved in the ability ofCa2/ to stimulate
osteoblastic chemotaxis (Godwin, et al., 1997). Hence, the ERK signaling pathway is a
likely candidate to be involved in the Ca2+ induction ofCOX-2 expression.
There is to date much controversy whether or not bone cells express the same
extracellular Ca2+ receptor (CAR) as that idemified in parathyroid and kidney cells. It is
clear that bone cells possess a calcium sensing mechanism, but it cannot be proven that
this is the CaR isolated from parathyroid cells at this time. Our results demonstrate that a
calcium sensing mechanism does exist on primary calvarial osteoblasts, but whether this
mechanism resembles the CaR was not determined through our study.
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Since bone remodeling is a key feature during tooth movemem, it is therefore of
great imerest to the orthodomist. Previous studies have shown that extracellular calcium
may serve as a coupling agem between bone formation and resorption, by inhibiting
osteoclastic activity and stimulating chemotaxis and mitogenesis of osteoblasts (Godwin,
et al., 1996). It has been shown that calcium is released locally in levels as high as 40
rnvl in sites ofbone resorption (Silver, et al., 1988). It would be of imerest to determine
whether the extracellular calcium environmem can be regulated locally to enhance or
inhibit tooth movemem.
On a systemic level, drugs that act on the Ca2+ receptor to alter circulating levels
ofPTH and calcitonin might provide novel treatmems for osteoporosis and for
hyperparathyroidism. Calcimimetic and calcilytic compounds could provide new
therapeutic options in preveming and treating various bone and mineral disorders. Since
this receptor is expressed on many other cell types, drugs acting on Ca2/ receptors could
be useful in treating disorders beyond those involving bone and mineral metabolism
(Nemeth, 1996).
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